Humanigen Inc (fka HGENQ)

[cowtown jay]

The definitive evidence for Regulatory Approval of Lenzilumab is presented by the trial doctors who conducted the company-sponsored LIVE-AIR trial. Those results are presented and discussed by the trial investigators in the following 36 minute video. It should be noted that the first 10 minutes of the video discusses a case cohort study conducted by Mayo Clinic, as a pre-cursor to implementing the Phase III trial by Humanigen. Select the option to watch the video on Youtube.